Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Contineum Therapeutics (CTNM) Interest Expenses (2023)

Historic Interest Expenses for Contineum Therapeutics (CTNM) over the last 1 years, with Q2 2023 value amounting to $116000.0.

  • Contineum Therapeutics' Interest Expenses changed N/A to $116000.0 in Q2 2023 from the same period last year, while for Mar 2024 it was $116000.0, marking a year-over-year change of. This contributed to the annual value of $208000.0 for FY2023, which is N/A changed from last year.
  • Per Contineum Therapeutics' latest filing, its Interest Expenses stood at $116000.0 for Q2 2023.
  • Contineum Therapeutics' Interest Expenses' 5-year high stood at $116000.0 during Q2 2023, with a 5-year trough of $92000.0 in Q1 2023.